Hillsborough, CA, United States of America

Steven Shak

This inventor holds 24 USPTO granted patents and 16 published patent applications, plus 11 CIPO patents and 17 EPO patents. Top assignees: Genomic Health, Inc., Nsabp Foundation, Inc., Bristol-Myers Squibb Compnay. Active years: 2006-2025.

USPTO Granted Patents = 24 (Patent Applications = 16)

% Patents Active = 95.8

CIPO Patents = 11 (Patent Applications = 8)

EPO Patents = 17 (Patent Applications = 21)

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 346(Granted Patents)

Company Filing History:

Nsabp Foundation, Inc.

patents

1 out of 3,735

Bristol-Myers Squibb Compnay

patents

4. 1 out of 1

Instituto Nazionale Tumori

patent

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12412642 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2025-09-09),

2. 11776664 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2023-10-03),

3. 11551782 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2023-01-10),

4. 11220715 - Gene expression markers for breast cancer prognosis (2022-01-11),

5. 11011252 - Gene expression profile algorithm and test for determining prognosis of prostate cancer (2021-05-18),

6. 10892038 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2021-01-12),

7. 10619215 - Prediction of likelihood of cancer recurrence (2020-04-14),

8. 10260104 - Method for using gene expression to determine prognosis of prostate cancer (2019-04-16),

9. 10181008 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2019-01-15),

10. 10179936 - Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy (2019-01-15),

11. 9944990 - Gene expression markers for breast cancer prognosis (2018-04-17),

12. 9605318 - Gene expression markers for predicting response to chemotherapy (2017-03-28),

13. 9551034 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2017-01-24),

14. 8868352 - Predicting response to chemotherapy using gene expression markers (2014-10-21),

15. 8273534 - Predictors of patient response to treatment with EGF receptor inhibitors (2012-09-25),

Title: The Innovative Journey of Steven Shak

Introduction: Steven Shak, a renowned inventor hailing from Hillsborough, CA, has made significant contributions to the field of biotechnology with his groundbreaking innovations.

Latest Patents: Steven Shak holds several patents in the field of medical diagnostics, including a recent patent for a novel cancer detection technology that has revolutionized early diagnosis methods.

Career Highlights: With a career spanning over two decades, Steven Shak has worked tirelessly to bridge the gap between technology and healthcare, leading to the development of cutting-edge diagnostic tools that have saved countless lives.

Collaborations: Throughout his career, Steven Shak has collaborated with leading research institutions, universities, and biotech companies to further advance his inventions and bring them to the market, solidifying his reputation as a pioneer in the industry.

Conclusion: Steven Shak's passion for innovation and his dedication to improving healthcare through technology have cemented his legacy as a visionary inventor in the field of biotechnology.